| Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease E Sidransky, MA Nalls, JO Aasly, J Aharon-Peretz, G Annesi, ER Barbosa, ... New England Journal of Medicine 361 (17), 1651-1661, 2009 | 2352 | 2009 |
| Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A S Züchner, IV Mersiyanova, M Muglia, N Bissar-Tadmouri, J Rochelle, ... Nature genetics 36 (5), 449-451, 2004 | 1903 | 2004 |
| The challenge of mapping the human connectome based on diffusion tractography KH Maier-Hein, PF Neher, JC Houde, MA Côté, E Garyfallidis, J Zhong, ... Nature communications 8 (1), 1349, 2017 | 1239 | 2017 |
| Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use M Abdollahi, M Cushman, FR Rosendaal Thrombosis and haemostasis 89 (03), 493-498, 2003 | 621 | 2003 |
| Collaborative analysis of α-synuclein gene promoter variability and Parkinson disease DM Maraganore, M De Andrade, A Elbaz, MJ Farrer, JP Ioannidis, ... Jama 296 (6), 661-670, 2006 | 620 | 2006 |
| Random forest algorithm for the classification of neuroimaging data in Alzheimer's disease: a systematic review A Sarica, A Cerasa, A Quattrone Frontiers in aging neuroscience 9, 329, 2017 | 610 | 2017 |
| The nicotinic receptor β2 subunit is mutant in nocturnal frontal lobe epilepsy MD Fusco, A Becchetti, A Patrignani, G Annesi, A Gambardella, ... Nature genetics 26 (3), 275-276, 2000 | 571 | 2000 |
| Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2 A Bolino, M Muglia, FL Conforti, E LeGuern, MAM Salih, DM Georgiou, ... Nature genetics 25 (1), 17-19, 2000 | 566 | 2000 |
| A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies MA Nalls, R Duran, G Lopez, M Kurzawa-Akanbi, IG McKeith, ... JAMA neurology 70 (6), 727-735, 2013 | 501 | 2013 |
| Mutations in a Sar1 GTPase of COPII vesicles are associated with lipid absorption disorders B Jones, EL Jones, SA Bonney, HN Patel, AR Mensenkamp, ... Nature genetics 34 (1), 29-31, 2003 | 447 | 2003 |
| MR Imaging Index for Differentiation of Progressive Supranuclear Palsy from Parkinson Disease and the Parkinson Variant of Multiple System Atrophy1 A Quattrone, G Nicoletti, D Messina, F Fera, F Condino, P Pugliese, ... Radiology 246 (1), 214-221, 2008 | 446 | 2008 |
| Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control study OA Ross, AI Soto-Ortolaza, MG Heckman, JO Aasly, N Abahuni, G Annesi, ... The Lancet Neurology 10 (10), 898-908, 2011 | 356 | 2011 |
| Mutation in the SYNJ1 Gene Associated with Autosomal Recessive, Early‐Onset Parkinsonism M Quadri, M Fang, M Picillo, S Olgiati, GJ Breedveld, J Graafland, B Wu, ... Human mutation 34 (9), 1208-1215, 2013 | 345 | 2013 |
| UCHL1 is a Parkinson's disease susceptibility gene DM Maraganore, TG Lesnick, A Elbaz, MC Chartier‐Harlin, T Gasser, ... Annals of neurology 55 (4), 512-521, 2004 | 336 | 2004 |
| Machine learning on brain MRI data for differential diagnosis of Parkinson's disease and Progressive Supranuclear Palsy C Salvatore, A Cerasa, I Castiglioni, F Gallivanone, A Augimeri, M Lopez, ... Journal of neuroscience methods 222, 230-237, 2014 | 310 | 2014 |
| Ascorbic acid in Charcot–Marie–Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial D Pareyson, MM Reilly, A Schenone, GM Fabrizi, T Cavallaro, L Santoro, ... The Lancet Neurology 10 (4), 320-328, 2011 | 292 | 2011 |
| Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy G Nicoletti, R Lodi, F Condino, C Tonon, F Fera, E Malucelli, D Manners, ... Brain 129 (10), 2679-2687, 2006 | 274 | 2006 |
| Magnetic resonance imaging biomarkers for the early diagnosis of Alzheimer's disease: a machine learning approach C Salvatore, A Cerasa, P Battista, MC Gilardi, A Quattrone, I Castiglioni, ... Frontiers in neuroscience 9, 307, 2015 | 272 | 2015 |
| Sex differences in clinical and genetic determinants of levodopa peak-dose dyskinesias in Parkinson disease: an exploratory study M Zappia, G Annesi, G Nicoletti, G Arabia, F Annesi, D Messina, ... Archives of neurology 62 (4), 601-605, 2005 | 271 | 2005 |
| Identification of an Nav1. 1 sodium channel (SCN1A) loss-of-function mutation associated with familial simple febrile seizures M Mantegazza, A Gambardella, R Rusconi, E Schiavon, F Annesi, ... Proceedings of the National Academy of Sciences 102 (50), 18177-18182, 2005 | 260 | 2005 |
